Part 2 I interacted with a seventy-four-year-old Hispanic American with AD. According to her family (spouse and two children), the patient was diagnosed with AD five years ago. They report that she has struggled with medication adherence for the past five years. Currently, she presents with muscle twitches, confusion, and vocalization of repetitive statements. Additional evaluation reveals that the patient experiences difficulty recognizing her children. The patient’s spouse reports that the patient has demonstrated anterograde amnesia over the past two months. Her thought process and impulse control are preserved. As such, the patient is likely to have moderate Alzheimer’s disease. I spent five hours with the patient and her family. During our interaction, I learned that the patient and her family have low digital literacy. According to them, they have never used any form of healthcare technology. I educated them on the importance of healthcare technology. At the end of our interaction, they agreed to embrace telehealth technology, such as message reminders offered by mobile health. I sought my evidence from organizational websites and online databases. Notably, I used PubMed and Google Scholar. During my research, I learned that low digital literacy impacts the use of technology. This can be addressed by patient and family education. Technology will enable healthcare providers to manage AD adequately and reduce healthcare costs caused by AD-associated hospitalizations. References ALZ.org. (n.d.). Programs and Support. https://www.alz.org/help-support/i-have-alz/programs-support#:~:text=Call%20the%20Alzheimer’s%20Association%2024,crisis%20assistance%3B%20and%20emotional%20support. De Marchi, F., Contaldi, E., Magistrelli, L., Cantello, R., Comi, C., & Mazzini, L. (2021). Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians. Brain Sciences, 11(2), 1–20. https://doi.org/10.3390/brainsci11020237
Get 20% discount on your first order